TrialVaccine2022

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.

Libia Milena Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.